Professional Documents
Culture Documents
the human immunodeficiency virus (HIV)-positive population. In the United States, tuberculosis has been on the rise since 1986 (13), with
an increase in extrapulmonary manifestations
as well (4). Approximately 30% of patients with
tuberculosis are HIV seropositive (5, 6). Conversely, 5% to 9% of all AIDS patients have
tuberculosis (all sites included) (2, 7, 8). Central nervous system (CNS) tuberculosis occurs
in 2% to 5% of all patients with tuberculosis (9,
10) and in 10% of those with AIDS-related tuberculosis (9, 11).
Although toxoplasma encephalitis and CNS
lymphoma are more commonly encountered in
HIV-infected patients, CNS tuberculosis is
clearly a significant cause of cerebral infection.
Because prompt diagnosis may result in earlier
1319
1320
WHITEMAN
No. of Patients
16
2
2
1
2
1
In all 24 cases, CNS infection was attributable to mycobacterium tuberculosis. The remaining patient, a 3-yearold, was diagnosed on the basis of clinical grounds and
radiographic findings. CSF studies in this child revealed a
glucose of 38.5 mg/dL, a protein of 188 mg/dL, and a CSF
white blood cell count of 143/mm3 with 31% polymorphonuclear leukocytes and 69% monocytes. Chest x-ray revealed a miliary pattern. This patient demonstrated rapid
clinical and laboratory improvement after treatment with
antituberculosis medication.
Results
Imaging
The following neuroimaging findings occurred with the frequency shown in these 25
HIV-infected patients with CNS tuberculosis:
Radiographic Finding
Cisternal/meningeal enhancement
Hydrocephalus
Enhancing parenchymal lesions
Infarction
No. of Patients
9
8
11
9
(36%)
(32%)
(44%)
(36%)
The basal cisterns were a favored site of meningeal enhancement; of the 9 patients with meningeal enhancement, 6 (24% of the total study
population) demonstrated enhancement of the
basal cisterns. Five of the 8 cases of hydrocephalus were associated with meningeal enhancement (Fig 1). In 2 patients, hydrocephalus was
the sole finding. The 11 cases with focal enhancing parenchymal lesions included 5 cases
of cerebral tuberculous abscess and 6 cases of
granulomata (tuberculomas). The enhancing
lesions were defined as granulomata versus abscess based on their radiographic appearance.
All five abscesses were solitary lesions with ring
enhancement, mass effect, and edema. Three
of the five abscess lesions were more than 3 cm
in size, three were multiloculated, and three
were located in the posterior fossa. Four of the
five abscesses were confirmed at surgery.
Tuberculomas had a different radiographic
appearance. Tuberculomas were noted in 6
(24%) of 25 patients and were 1 cm or less in
size. Both nodular (n 5 4) and ring-enhancing
(n 5 2) patterns were observed (Fig 2). The
tuberculomas demonstrated little or no mass
effect and little edema (Fig 3). These lesions
were either multiple (n 5 4) or solitary (n 5 2).
Three of the six patients with tuberculomas had
only supratentorial lesions, one patient had both
supratentorial and infratentorial granulomata,
and two patients had only infratentorial tuberculomas. Of the three patients with infratentorial lesions, two patients had lesions of the vermis, and two patients had lesions at the
periphery of the brainstem, near an adjacent
cistern. Of the four patients with supratentorial
lesions, three had lesions that were adjacent to
CSF spaces, either periventricular or perisylvian
in location. Two of the four patients with supratentorial lesions had involvement of the corticomedullary junction, and one of the four pa-
TUBERCULOSIS IN HIV
1321
1322
WHITEMAN
Clinical
Clinical findings were as follows in these 25
patients:
Sign/Symptom
Fever
Headache
Altered mental status
Cough
Nausea/vomiting
Meningismus
Shortness of breath
Seizures
Patients, %
54
50
42
33.3
21
17
13
4
Information on drug susceptibility was available for 19 patients. Seven (37%) of 19 patients
TUBERCULOSIS IN HIV
1323
infections and no evidence of pulmonary tuberculosis, and thus CNS tuberculosis was the first
manifestation of AIDS in those patients.
Overall mortality was high, at 79%. A 67%
mortality was seen within 2 months of diagnosis, and a 71% mortality was noted by 1 year
after diagnosis. The mortality was directly attributable to tuberculosis in 90% of those patients who died.
Discussion
There has been a resurgence of tuberculosis
in the United States, particularly among HIVinfected patients (13). CNS involvement is
present in approximately 10% of those with
AIDS-related tuberculosis (9, 11), but in only
2% to 5% of those with nonAIDS-related tuberculosis (9, 10). It is therefore important for the
radiologist to recognize this disease so that appropriate therapy may be promptly instituted.
Meningeal enhancement was observed in
36% of patients in this study. The cause of this
enhancement is a basal leptomeningitis. Two
different mechanisms have been proposed for
the pathogenesis of tuberculosis meningitis
(1214). The first theory suggests rupture of
subependymal or subpial granulomata into the
CSF. The other proposed mechanism involves
1324
WHITEMAN
Fig 5. Infarction in a pediatric AIDS patient. Contrast-enhanced CT scan of a 3-year-old AIDS patient with CNS tuberculosis. Calcification is seen in the basal ganglia bilaterally, which is
often present in HIV-infected children. The calcification is thought
to be attributable to a calcific vasopathy and is a direct result of
HIV infection. In addition, there is hypodensity involving the left
globus pallidus, the caudate head, and the anterior limb of the left
internal capsule. These infarctions were presumed to be a result of
CNS tuberculosis. Rapid clinical improvement was evident after
treatment with antituberculous therapy.
TUBERCULOSIS IN HIV
1325
HIV1 Study
Population?
No. of Study
Patients
Meningeal
Disease
Hydrocephalus
Infarcts
Berenguer et al (9)
Jinkins (22)
Chang et al (23)
Bhargava et al (29)
Berenguer et al (9)
Villoria et al (20)
Present study
no
no
no
no
yes
yes
yes
16
80
26
60
26
35
25
6%
29%
39%
82%
23%
45%
36%
44%
40%
58%
83%
42%
51%
32%
6%
12.5%
42%
28%
27%
23%
36%
Enhancing Parenchymal
Lesions
0%
83%
231%
10%
15%
37%
44%
1326
WHITEMAN
culosis suggest a four-drug regimen of isoniazid, rifampin, pyrazinamide, and either streptomycin or ethambutol (34) for 2 months. Drug
susceptibility testing should be performed on
the first positive tuberculosis isolate. When drug
susceptibility results are available, treatment
should be altered as appropriate. In HIV-infected patients, this treatment regimen should
continue for a total of 9 months (34).
Acknowledgment
We thank Jean Alli for her assistance in preparation of
this manuscript.
References
1. Block AB, Reider HL, Kelly GD, et al. The epidemiology of tuberculosis in the United States: implications for diagnosis and treatment. Clin Chest Med 1989;10(3):297313
2. Center for Disease Control. Tuberculosis and acquired immunodeficiency syndrome: New York City. MMWR 1987;36:785795
3. Reider HL, Cauthen GM, Kelly GD, et al. Tuberculosis in the United
States. JAMA 1989;262:385389
4. Mehta JB, Dutt A, Harvill L, et al. Epidemiology of extrapulmonary
tuberculosis: a comparative analysis with pre-AIDS era. Chest
1991;99:1134 1138
5. Pitchenik AE, Burr J, Suarez M, et al. Human T-cell lymphotropic
virus-III (HTLV-III) seropositivity and related disease among 71
consecutive patients in whom tuberculosis was diagnosed: a prospective study. Am Rev Respir Dis 1987;135:875 879
6. Theur CP, Hopewell PC, Elias D, et al. Human immune deficiency
virus infection in tuberculosis patients. J Infect Dis 1990;162:8 12
7. Louie E, Rice LB, Holzman RS. Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome. Chest 1986;
90(4):542545
8. Tuberculosis and AIDS: Connecticut. MMWR 1987;36:133135
9. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in
patients infected with the human immunodeficiency virus. N Engl
J Med 1992;326:668 672
10. Curless RG, Mitchell CD. Central nervous system tuberculosis in
children. Pediatr Neurol 1991;7:270 274
11. Bishburg E, Sunderam G, Reichman LB, Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency
syndrome and its related complex. Ann Intern Med 1986;105:
210 213
12. Sze G, Zimmerman RD. The magnetic resonance imaging of
infection and inflammatory diseases. Radiol Clin North Am 1988;
26:839 859
13. Zimmerman RA, Bilaniuk LT, Sze G. Intracranial infection. In:
Brant-Zawadzki M, Norman D, eds. Magnetic Resonance Imaging
of the Central Nervous System. New York: Raven Press, 1987;
235257
14. Sheller JR, DesPrez RM. CNS tuberculosis. Neurol Clin 1986;4:
143158
15. Parker JC Jr, Dyer MC. Neurologic infections due to bacteria,
fungi and parasites. In: Doris RL, Robertson DM, eds. Textbook of
Neuropathology. Baltimore: Williams & Wilkins, 1985;632703
16. Tyson G, Newman P, Strachen WE. Tuberculous brain abscess.
Surg Neurol 1978;10:323325
17. Whitener DR. Tuberculous brain abscess: report of a case and
review of the literature. Arch Neurol 1978;35:148 155
TUBERCULOSIS IN HIV
1327